Status:
COMPLETED
the PrEsentation, Rationale and Impact of reperFUSION for Acute Coronary Syndromes in Cape Town and the Garden Route Health District - the PERFUSION Registry
Lead Sponsor:
University of Cape Town
Conditions:
Acute Coronary Syndrome
ST Elevated Myocardial Infarction
Eligibility:
All Genders
18+ years
Brief Summary
The global burden and threat of non-communicable diseases (NCDs) have become a major health challenge that undermines social and economic development throughout the world. Cardiovascular disease inclu...
Detailed Description
The investigators propose to set up and conduct a multi-centre, prospective, observational registry to describe the demographics, clinical characteristics, presentation, management and outcomes of pat...
Eligibility Criteria
Inclusion
- signed written informed consent before any study recruitment; and
- male or female patients age ≥ 18 years of age; and
- a diagnosis of ACS (STEMI, NSTEMI or UA).
Exclusion
- ACS absent within index admission; or
- refusal of consent
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2022
Estimated Enrollment :
870 Patients enrolled
Trial Details
Trial ID
NCT04887571
Start Date
February 1 2021
End Date
May 31 2022
Last Update
June 26 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Groote Schuur Hospital
Cape Town, Western Cape, South Africa, 7295
2
Victoria Hospital
Cape Town, Western Cape, South Africa, 7800
3
New Somerset Hospital
Cape Town, Western Cape, South Africa, 8001
4
George Hospital
George, Western Cape, South Africa, 6529